Revenue, 2025
USD 7.18 Bn
Forecast Year, 2034
USD 19.26 Bn
CAGR, 2025 - 2034
11.60%
Report Coverage
Worldwide
The global non-invasive prenatal testing market, valued at USD 7.18 billion in 2025, is projected to reach USD 19.26 billion by 2034, growing at a CAGR of 11.6%, driven by rising prenatal screenings, technological advancements, and increasing awareness.
Non-Invasive Prenatal Testing Market Size Analysis
Non-Invasive Prenatal Testing Market Size By Component 2025 to 2034 (USD Billion)
| Component | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Instruments | 1.79 | 2.00 | 2.23 | 2.49 | 2.78 | 3.10 | 3.46 | 3.87 | 4.31 | 4.81 |
| Kits and Reagents | 3.59 | 4.00 | 4.47 | 4.99 | 5.57 | 6.21 | 6.93 | 7.74 | 8.63 | 9.64 |
| Services | 1.80 | 2.01 | 2.24 | 2.50 | 2.79 | 3.11 | 3.48 | 3.88 | 4.33 | 4.83 |
Non-Invasive Prenatal Testing Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Down Syndrome (trisomy 21) | 3.94 | 4.40 | 4.91 | 5.48 | 6.11 | 6.82 | 7.61 | 8.49 | 9.48 | 10.58 |
| Edwards Syndrome (trisomy 18) | 1.08 | 1.20 | 1.34 | 1.50 | 1.67 | 1.86 | 2.08 | 2.32 | 2.59 | 2.89 |
| Patau Syndrome (trisomy 13) | 0.72 | 0.80 | 0.90 | 1.00 | 1.12 | 1.25 | 1.39 | 1.55 | 1.73 | 1.93 |
| Turner Syndrome | 0.72 | 0.81 | 0.90 | 1.00 | 1.12 | 1.25 | 1.39 | 1.56 | 1.74 | 1.94 |
| Other Applications | 0.72 | 0.81 | 0.90 | 1.01 | 1.12 | 1.25 | 1.40 | 1.56 | 1.74 | 1.94 |
Non-Invasive Prenatal Testing Market Size By End User 2025 to 2034 (USD Billion)
| End User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 3.44 | 3.84 | 4.29 | 4.79 | 5.34 | 5.96 | 6.65 | 7.42 | 8.29 | 9.25 |
| Diagnostic Labs | 3.74 | 4.17 | 4.65 | 5.19 | 5.80 | 6.47 | 7.22 | 8.06 | 8.99 | 10.03 |
Non-Invasive Prenatal Testing Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.72 | 3.04 | 3.39 | 3.78 | 4.22 | 4.71 | 5.26 | 5.87 | 6.55 | 7.31 |
| Europe | 1.86 | 2.08 | 2.32 | 2.59 | 2.89 | 3.23 | 3.60 | 4.02 | 4.49 | 5.01 |
| Asia Pacific | 1.58 | 1.76 | 1.97 | 2.20 | 2.45 | 2.73 | 3.05 | 3.40 | 3.80 | 4.24 |
| Latin America | 0.58 | 0.65 | 0.72 | 0.80 | 0.90 | 1.00 | 1.12 | 1.25 | 1.39 | 1.55 |
| Middle East and Africa | 0.44 | 0.49 | 0.54 | 0.61 | 0.68 | 0.76 | 0.84 | 0.94 | 1.05 | 1.17 |
Non-Invasive Prenatal Testing Market Size to Worth USD 19.26 Billion by 2034
The global non-invasive prenatal testing market size was calculated at USD 7.18 billion in 2025 and is predicted to attain around USD 19.26 billion by 2034 a CAGR of 11.6%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com